78 related articles for article (PubMed ID: 18250036)
1. [Effects of carbon-coated iron nanocrystals combined with epirubicin on HepG-2 cells and its acute toxicity in mice].
Zheng Y; Lao XM; Zhang HY; Chen YM; Chen MS; Yuan YF; Zhang YQ; Li JQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):176-9. PubMed ID: 18250036
[TBL] [Abstract][Full Text] [Related]
2. [Adsorption and sustained release of epirubicin from carbon-coated iron nanocrystals].
Lao XM; Zhang HY; Li JQ; Chen YM; Huang JT; Zhang YQ; Zheng Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1331-4. PubMed ID: 18753052
[TBL] [Abstract][Full Text] [Related]
3. [Acute toxicity of carbon-coated iron nanocrystal and its effect on liver and kidney functions and hematological system].
Lao XM; Zhang HY; Li JQ; Chen YM; Chen MS; Yuan YF; Zhang YQ; Zheng Y
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1471-5. PubMed ID: 17959516
[TBL] [Abstract][Full Text] [Related]
4. Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studies.
Gao F; Li L; Zhang H; Yang W; Chen H; Zhou J; Zhou Z; Wang Y; Cai Y; Li X; Liu L; Zhang Q
Int J Pharm; 2010 Jun; 392(1-2):254-60. PubMed ID: 20347028
[TBL] [Abstract][Full Text] [Related]
5. Epirubicin HCl toxicity in human-liver derived hepatoma G2 cells.
Ozkan A; Fişkin K
Pol J Pharmacol; 2004; 56(4):435-44. PubMed ID: 15520498
[TBL] [Abstract][Full Text] [Related]
6. In vitro anticancer activity of doxorubicin-loaded gelatin-coated magnetic iron oxide nanoparticles.
Gaihre B; Khil MS; Kim HY
J Microencapsul; 2011; 28(4):286-93. PubMed ID: 21545319
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging.
Cho WS; Cho M; Kim SR; Choi M; Lee JY; Han BS; Park SN; Yu MK; Jon S; Jeong J
Toxicol Appl Pharmacol; 2009 Aug; 239(1):106-15. PubMed ID: 19520096
[TBL] [Abstract][Full Text] [Related]
8. FePt@CoS(2) yolk-shell nanocrystals as a potent agent to kill HeLa cells.
Gao J; Liang G; Zhang B; Kuang Y; Zhang X; Xu B
J Am Chem Soc; 2007 Feb; 129(5):1428-33. PubMed ID: 17263428
[TBL] [Abstract][Full Text] [Related]
9. Improved antitumor activity of epirubicin-loaded CXCR4-targeted polymeric nanoparticles in liver cancers.
Di-Wen S; Pan GZ; Hao L; Zhang J; Xue QZ; Wang P; Yuan QZ
Int J Pharm; 2016 Mar; 500(1-2):54-61. PubMed ID: 26748365
[TBL] [Abstract][Full Text] [Related]
10. Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells.
Roth S; Langguth P; Spicher K; Enzmann H
Transl Res; 2008 Jan; 151(1):36-44. PubMed ID: 18061126
[TBL] [Abstract][Full Text] [Related]
11. Reversal of multidrug resistance by tacrolimus hydrate.
Wu J; Furusawa S; Nakano S; Takahashi M; Chiba H; Takayanagi M; Takayanagi Y; Sasaki K
Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):651-8. PubMed ID: 9121220
[TBL] [Abstract][Full Text] [Related]
12. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
13. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.
Zhang HZ; Gao FP; Liu LR; Li XM; Zhou ZM; Yang XD; Zhang QQ
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):19-26. PubMed ID: 19186037
[TBL] [Abstract][Full Text] [Related]
14. Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.
Jalalian SH; Taghdisi SM; Shahidi Hamedani N; Kalat SA; Lavaee P; Zandkarimi M; Ghows N; Jaafari MR; Naghibi S; Danesh NM; Ramezani M; Abnous K
Eur J Pharm Sci; 2013 Oct; 50(2):191-7. PubMed ID: 23835028
[TBL] [Abstract][Full Text] [Related]
15. Medroxyprogesterone and tamoxifen augment anti-proliferative efficacy and reduce mitochondria-toxicity of epirubicin in FM3A tumor cells in vitro.
Altinoz MA; Bilir A; Gedikoglu G; Ozcan E; Oktem G; Muslumanoglu M
Cell Biol Int; 2007 May; 31(5):473-81. PubMed ID: 17198756
[TBL] [Abstract][Full Text] [Related]
16. Fenton activity and cytotoxicity studies of iron-loaded carbon particles.
Peebles B; Nagy A; Waldman WJ; Dutta PK
Environ Sci Technol; 2010 Sep; 44(17):6887-92. PubMed ID: 20695492
[TBL] [Abstract][Full Text] [Related]
17. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery.
Chang LC; Wu SC; Tsai JW; Yu TJ; Tsai TR
Int J Pharm; 2009 Jul; 376(1-2):195-203. PubMed ID: 19439169
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
19. Schedule-dependent effects of kappa-selenocarrageenan in combination with epirubicin on hepatocellular carcinoma.
Ji YB; Ling N; Zhou XJ; Mao YX; Li WL; Chen N
Asian Pac J Cancer Prev; 2014; 15(8):3651-7. PubMed ID: 24870773
[TBL] [Abstract][Full Text] [Related]
20. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
